The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 5 rounds in the feed, most often at Series B and in Healthtech.
CorporationSan Francisco, CA 94111yosemite.coRounds from 2025-01-13 to 2026-07-14
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Chai Discovery A company that develops AI models that predict and reprogram the interactions between molecules | Series C Verified against 4 of 12 sources[ REPORTED LATER ]: This round was announced before Fireround first saw it. It stays in the company's history, not in Latest, Trending, or alerts. | $400M | 2026-07-14 | [ PART ] |
Chai Discovery A company that develops AI models that predict and reprogram the interactions between molecules |
Series B Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. |
| $130M |
| 2025-12-14 |
| [ PART ] |
Solve Therapeutics Novel antibody-drug conjugates (ADCs) for cancer treatment targeted at solid tumors and optimized for payload delivery using proprietary technology. | Funding round Verified against 1 of 4 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $120M | 2025-11-17 | [ LEAD ] |
Chai Discovery A company that develops AI models that predict and reprogram the interactions between molecules | Series A Verified against 1 of 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $70M | 2025-08-06 | [ PART ] |
Tune Therapeutics TuneTx sells genetic tuning technology aimed at transforming health through gene and regenerative therapies, targeting diseases at their source. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $175M | 2025-01-13 | [ LEAD ] |